Hallahan DE - Search Results

1

A specific antagonist of the p110delta catalytic component of phosphatidylinositol 3'-kinase, IC486068, enhances radiation-induced tumor vascular destruction.

Geng L, Tan J, Himmelfarb E, Schueneman A, Niermann K, Brousal J, Fu A, Cuneo K, Kesicki EA, Treiberg J, Hayflick JS, Hallahan DE. Geng L, et al. Among authors: hallahan de. Cancer Res. 2004 Jul 15;64(14):4893-9. doi: 10.1158/0008-5472.CAN-03-3955. Cancer Res. 2004. PMID: 15256460

2

Gene therapy targeted by ionizing radiation.

Weichselbaum RR, Hallahan DE, Sukhatme VP, Kufe DW. Weichselbaum RR, et al. Among authors: hallahan de. Int J Radiat Oncol Biol Phys. 1992;24(3):565-7. doi: 10.1016/0360-3016(92)91075-x. Int J Radiat Oncol Biol Phys. 1992. PMID: 1399745 Review.

3

Inhibition of protein kinases sensitizes human tumor cells to ionizing radiation.

Hallahan DE, Virudachalam S, Schwartz JL, Panje N, Mustafi R, Weichselbaum RR. Hallahan DE, et al. Radiat Res. 1992 Mar;129(3):345-50. Radiat Res. 1992. PMID: 1542722

4

Tumor necrosis factor gene expression is mediated by protein kinase C following activation by ionizing radiation.

Hallahan DE, Virudachalam S, Sherman ML, Huberman E, Kufe DW, Weichselbaum RR. Hallahan DE, et al. Cancer Res. 1991 Sep 1;51(17):4565-9. Cancer Res. 1991. PMID: 1873801

5

p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas.

Brachman DG, Hallahan DE, Beckett MA, Yandell DW, Weichselbaum RR. Brachman DG, et al. Among authors: hallahan de. Cancer Res. 1991 Dec 1;51(23 Pt 1):6393-6. Cancer Res. 1991. PMID: 1933904

6

Genetic radiotherapy overcomes tumor resistance to cytotoxic agents.

Seung LP, Mauceri HJ, Beckett MA, Hallahan DE, Hellman S, Weichselbaum RR. Seung LP, et al. Among authors: hallahan de. Cancer Res. 1995 Dec 1;55(23):5561-5. Cancer Res. 1995. PMID: 7585635

7

Cellular and molecular mechanisms of radioresistance.

Weichselbaum RR, Beckett MA, Vokes EE, Brachman DG, Haraf D, Hallahan D, Kufe D. Weichselbaum RR, et al. Cancer Treat Res. 1995;74:131-40. doi: 10.1007/978-1-4615-2023-8_7. Cancer Treat Res. 1995. PMID: 7779612 Review. No abstract available.

8

Gene therapy targeted by radiation preferentially radiosensitizes tumor cells.

Weichselbaum RR, Hallahan DE, Beckett MA, Mauceri HJ, Lee H, Sukhatme VP, Kufe DW. Weichselbaum RR, et al. Among authors: hallahan de. Cancer Res. 1994 Aug 15;54(16):4266-9. Cancer Res. 1994. PMID: 8044769

9

Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature.

Mauceri HJ, Hanna NN, Wayne JD, Hallahan DE, Hellman S, Weichselbaum RR. Mauceri HJ, et al. Among authors: hallahan de. Cancer Res. 1996 Oct 1;56(19):4311-4. Cancer Res. 1996. PMID: 8813113

10

Cell adhesion molecules mediate radiation-induced leukocyte adhesion to the vascular endothelium.

Hallahan D, Kuchibhotla J, Wyble C. Hallahan D, et al. Cancer Res. 1996 Nov 15;56(22):5150-5. Cancer Res. 1996. PMID: 8912850

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters